Qube Research & Technologies (QRT)
LBPH

Qube Research & Technologies (QRT)’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,844
Closed -$495K – 3924
2024
Q3 		$495K Buy
+14,844
New +$511K ﹤0.01% 2274
2024
Q2 		– Sell
-55,137
Closed -$1.19M – 4977
2024
Q1 		$1.19M Buy
55,137
+2,694
+5% +$58.8K ﹤0.01% 2039
2023
Q4 		$316K Buy
+52,443
New +$261K ﹤0.01% 2551

Qube Research & Technologies (QRT)'s LBPH Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 14,844 shares — an estimated $495K sold.

Qube Research & Technologies (QRT) first reported a position in LBPH in Q4 2023 and held it in 3 quarters. The position peaked at $1.19M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,844 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $495K.
  • Qube Research & Technologies (QRT) first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.19M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.